As many as half of patients don’t take medications as prescribed, and 20% to 30% of prescriptions are never filled 1,2. This nonadherence to recommended treatment has dramatic effects on patients and the health care system. Lack of patient adherence leads to poor therapeutic outcomes...
Pharmacogenetics and medication decision support software can be used to find effective and safe antipsychotics for schizophrenia while preventing side effects. Schizophrenia is a severe, chronic mental health condition characterized by a variety of psychological and psychotic symptoms. Some of these symptoms may include hallucinations,...
The decision to quit smoking is a big step to improving your health. It is never too late to quit and the benefits include a reduction in cancer, heart and lung disease, and improved quality of life. When attempting to quit smoking, both counseling and smoking cessation...
Ticagrelor (Brilinta, Brilique, and Possia) is a platelet aggregation inhibitor used after a heart attack to prevent clots from forming and causing further heart attacks. At this moment, there no clear evidence for the use of pharmacogenetics for ticagrelor. PharmGKB, a NIH-funded database that curates knowledge...
TreatGx is a precision prescribing software (medication decision support system) that personalizes prescriptions to help reduce the risk of adverse drug reactions, increase medication efficacy and reduce healthcare costs. TreatGx goes beyond the individual’s genetic code and enables precision prescribing by detecting complex interactions including...
PharmGKB is a publicly available internet research tool that provides information about how genetic variation among individuals contributes to differences in reactions to drugs. Developed by Stanford University and funded by the National Institutes of Health (NIH), PharmGKB is the largest pharmacogenetic database. The information in...
The team at GenXys is excited to announce that Gastroesophageal Reflux Disease, H. pylori Eradication and Dyspepsia/Peptic Ulcer Disease are now covered by TreatGxPlus (pharmacogenetic test and decision support system). H. pylori Eradication Helicobacter pylori is a bacterium that infects your stomach. Most people don’t realize they...
The most up to date evidence does not support the use of SLC47A2 variants to predict glycemic response to metformin in diabetes Type 2 diabetes Type 2 diabetes is a chronic condition that affects the way the body metabolizes glucose (sugar) and is characterized by high levels...
The team at Genxys is excited to announce that Post-Myocardial Infarction (Heart Attack) and Smoking Cessation are now covered in TreatGxPlus (pharmacogenetic test and decision support system). Post-Myocardial Infarction (Heart Attack) A myocardial infarction (MI) is also known as a heart attack. This occurs when the heart...
The TreatGxPlus pharmacogenetic test was developed using an evidence-based approach, following a rigorous review process of scientific studies and professional guidelines. This process allows us to select genetic variants with strong evidence for a significant clinical outcome indicating a change in dose of a medication,...